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Objective 
Our group recently showed that animal protein was independently associated with non-
alcoholic fatty liver disease (NAFLD). We hypothesize that this may be explained by a high 
diet-dependent acid load (DAL). 
Methods 
This cross-sectional study is embedded in a prospective population-based cohort. We 
estimated DAL-proxies via food-frequency questionnaires using potential renal acid load 
(PRAL; using dietary protein, phosphorus, potassium, calcium, and magnesium intake), net 
endogenous acid production (NEAP; using protein and potassium intake), and animal-
protein-to-potassium-ratio (A:P). We defined NAFLD using ultrasound after excluding 
secondary steatogenic causes. We used logistic regression models –adjusted for socio-
demographic, lifestyle, and metabolic traits– on categorized (Q1-Q4) and continuous DAL-
proxies (allowing for non-linearity) and NAFLD.  
Results 
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We included 3882 participants of which 1337 had NAFLD. All DAL-proxies were higher, 
meaning more acidic, in individuals with NAFLD (PRAL: -2.9 vs -5.5mEq/day; NEAP: 37.0 
vs 35.1mEq/day, and AP:13.3 vs 12.4; all P<0.001). The highest quartile of DAL-proxies 
was associated with NAFLD independent of socio-demographic and lifestyle confounders, 
but significance dissipated after correction for metabolic confounders and multiple testing. 
However, the P-value for non-linearity was significant in all DAL-proxies (P<0.001). Natural 
cubic splines performed better with than without DAL-proxies in the fully adjusted model (all 
P≤0.038). The highest probability of NAFLD was found for an acidic diet. 
Conclusions 
This study showed an independent non-linear associati n between an acidic diet and NAFLD. 
Further studies with acid-base biomarkers are needed, but our findings might provide a 
mechanistic explanation for the harmful association between an animal protein-rich diet and 
NAFLD. 
In this population-based cohort (n=3882), there is a non-linear, independent association between 
dietary acid load &amp; NAFLD, which may explain the previous found link between animal protein 
&amp; NAFLD. 
Introduction 
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide with 
an estimated prevalence of 25% in the adult population(1). Its occurrence closely parallels the 
obesity epidemic. Obesity and insulin resistance are therefore reckoned as novel risk factors 
for liver disease in absence of the traditional risk factors, i.e. alcohol misuse or viral 
hepatitis(2). NAFLD can progress to more severe livr disease with hepatic fibrosis or 
cirrhosis potentially leading to need for transplantation or even liver-related death(3). In 
addition, NAFLD is a major risk factor for incidence ardiovascular disease(4), and indeed 
the most common cause of death in NAFLD is related to cardiovascular events(5). Given the 
above, it is of great public health interest to unravel NAFLD pathophysiology in order to 
improve understanding and treatment thereof. 
Adhering to a healthy lifestyle, in terms of implemnting a well-balanced diet and 
effectuating adequate physical activity, is the cornerstone of treatment of NAFLD across the 
entire spectrum of the disease(6,7). Our contemporary Western diet, on the other hand, is 
related with an increased risk of NAFLD development(8). This Western diet typically 
consists of a high intake of animal-based food products and sugar-containing beverages, and 
by low intake of fruit, vegetables and whole grains(9). Our group recently showed that animal 
protein was the only (subtype of) macronutrient thaw s independently associated with 
higher prevalence of NAFLD in an elderly population-based cohort(10). Interestingly, others 
have found that red meat intake was associated with increased overall mortality, and in 
particular with liver-related mortality(11). However, the underlying mechanisms that 
contribute to this association remain elusive. 
It has been previously postulated that a Western diet may cause low-grade metabolic 
acidosis, which may subsequently lead to metabolic disturbances such as type 2 diabetes(12) 
and cardiovascular diseases(13). The rationale for this hypothesis is that this diet is rich in 
food items that supply acid precursors (i.e. non-carbonic acids such as sulfuric acid from 
meat and fish) and low in food items that supply base precursors (i.e. alkali salts from organic 
acids such as citrate and bicarbonate from vegetables and fruits), leading to a disturbance in 
acid-base balance(14,15). Two preceding studies have suggested an association between diet-
dependent acid load (DAL) and NAFLD, independent of body mass index (BMI)(16,17). 
Amongst them, Krupp et al. showed that potential renal acid load (PRAL, a proxy of DAL), 
was associated with alanine aminotransferase (ALT) and steatosis, as defined by a surrogate 
diagnostic algorithm, in a small study of healthy adolescents(17). Moreover, Chan and 
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colleagues demonstrated that net endogenous acid production (NEAP, another proxy of DAL) 
but not PRAL, was associated with MRI-diagnosed NAFLD in a Chinese population 
(n=793)(16). In addition, two recent Japanese studies have showed an association between 
low urine pH (indicator of metabolic acidosis) and i cident NAFLD(18,19). 
To date, however, there has been no large-scale study on the association of diet-
dependent acid load and NAFLD in Western adults. We therefore aimed to evaluate if DAL 
(as assessed by PRAL, NEAP, and animal protein-to-po assium ratio [A:P]), was 
independently associated with ultrasound-defined NAFLD in an elderly Western population. 
Subjects and Methods 
Study Population 
This study is embedded in The Rotterdam Study, a prospective cohort study, that was 
initiated in the mid-1980s in order to study our aging population in more detail(20). The 
design and rationale behind The Rotterdam Study have been described in more detail 
previously(10,20) and is also described in the Supplementary Methods I(21). In short, all 
participants of The Rotterdam Study reside in Ommoord, a suburb of Rotterdam, the 
Netherlands, and all participants were aged 45 or 55 years or above at time of first 
enrollment. The Rotterdam Study consists of three diff rent cohorts (RS I, RS II, and RS III) 
that each visited the research centre multiple times. From 2009 onwards the hepatology 
department joined this research initiative by expanding the extensive physical work-up with 
liver imaging (this comprises cohort RS I-5, RS II-3, and RS III-2). The Rotterdam Study has 
been approved by the institutional review board (Medical Ethics Committee) of the Erasmus 
MC University Medical Centre Rotterdam and by the review board of The Netherlands 
Ministry of Health, Welfare, and Sports. Written informed consent was obtained from all 
participants. 
Dietary data and diet-dependent acid load 
We requested all participants to complete an externally validated, semi-quantitative, 389-item 
food frequency questionnaire (FFQ) that was developed for Dutch adults(22,23). Habitual 
dietary intake was assessed by means of detailed qustions on food item consumption over 
the last month that addressed not only type of food, but also quantity, portion size, and 
preparation methods. Servings were estimated in grams or in milligrams per day using 
standardised household measures(24). We extracted macronutrient intake from the 
questionnaires using the Dutch Food Composition Table (NEVO v2011) that contains 
information on nutrient content per gram or serving per product. DAL was calculated using 
three previously defined algorithms, which we will refer to as DAL-proxies from this point 
forward. The DAL-proxies included: 1) potential renal acid load (PRAL)(25), 2)  net 
endogenous acid production (NEAP)(15), and 3) animal protein-to-potassium ratio (A:P)(26).  
Remer and Manz developed PRAL to proxy the renal net acid excretion using nutrient 
intake data(25). PRAL was validated against urine pH in 24 hour urine samples from 63 
healthy volunteers (25).  
 
( )( ) [ ]
[ ]
[ ]
[ ]
[ ]
PRAL mEq / day 25              0.4888  protein g / day  
0.0366  phosphorus mg / day  
0.0205  potassium mg / day  
0.0125  calcium mg / day  –
0.0263  magnesium mg / day
= × +
× −
× −
×
×
  
Shortly after, Frassetto et al. developed a simplified algorithm (NEAP) using dietary 
protein as acid precursor and potassium only, as base precursor from organic anions(15). This 
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algorithm was validated in 141 healthy men and women consuming 20 different diets, and 
NEAP accounted for over 70% of the variation in renal net acid excretion.  
 
( )( ) [ ] [ ]( )NEAP mEq / day 15          54.5  protein g / day  /  potassium mEq / day  –  10.2= ×
  
Finally, Zwart and colleagues suggested the use of the ratio between animal protein intake 
and potassium intake instead of total dietary protein, as animal protein is considered to be the 
main contributor to diet-dependent acid load(26,27). 
 
( ) [ ] [ ]A:P 26                   animal protein g /day  /  potassium g / day=
  
We assessed adherence to the Dutch Dietary Guidelines 2015, using a predefined index 
that describes a general advice to follow a balanced and healthy dietary pattern(28), in order 
to assess dietary quality (DQ). Briefly, this guidelin  comprises specified recommendations 
on I) vegetables(≥200g/day), II) fruit (≥200g/day), III) whole-grain products (≥90g/day), IV) 
legumes (≥135g/week), V) unsalted nuts (≥15g/day), VI) fish (≥100g/week), VII) dairy 
(≥350g/day), VIII) tea (≥150mL/day), IX) whole grains ≥50% of total grains, X) unsaturated 
fats and oils ≥50% of total fats, XII) red and processed meat <300g/week, XIII) sugar-
containing beverages (≤150mL/day), XIV) alcohol (≤10 g/day), and XV) salt (≤6 g/day). 
Incomplete FFQs were excluded as well as FFQs with unreliable energy intake (i.e. <500 
calories/day or ≥7500 calories/day). 
Assessment of steatosis 
Abdominal ultrasound was performed by a certified an experienced technician on a Hitachi 
HI VISION 900 (PvW). Ultrasound images were stored digitally so re-evaluation by an 
experienced hepatologist (RdK) was possible. All FFQs were filled in prior to liver imaging, 
so participants were unaware of the ultrasound results when completing the FFQ. Diagnosis 
of steatosis was determined dichotomously(29), measuring the hyper-echogenicity of liver 
parenchyma. In order to define NAFLD, we first excluded participants that used steatogenic 
drugs (i.e. systemic corticosteroids, methotrexate, t moxifen or amiodarone). This was 
identified through linkage with pharmacy data. Second, participants with viral hepatitis were 
excluded, based on hepatitis B surface antigen and anti-hepatitis C virus serology which was 
assessed using an automatic immunoassay (Roche Diagnostic GmbH). And third, we 
excluded participants with excessive alcohol consumption (>30g/day for men and >20 g/day 
for women, based on the FFQ).  
Other Covariates 
We obtained data on demographics, physical activity, and education level by means of an 
extensive home interview by qualified interviewers. Briefly, physical activity was assessed 
using the LASA Physical Activity Questionnaire and expressed in metabolic equivalent of 
task (MET)hours/week(30). Blood pressure was measurd at a single visit using two 
successive measurements in a sitting position, and blood samples were collected after 
overnight fasting. Automatic enzyme procedures were used to measure blood lipids, platelet 
count, glucose, ALT, aspartate aminotransferase, and g mma-glutamyltransferase (Roche 
Diagnostic GmbH, Mannheim, DE). An automatic immunoassay was used to determine 
insulin (Roche Diagnostic GmbH). Estimated glomerula  filtration rate (GFR in [ml/min/1.73 
m2]) was based on calibrated creatinine levels using the CKD-EPI Creatinine Equation 
(2009). Creatinine levels were calibrated by alignin  mean values of serum creatinine from 
our cohort with those of the Third National Health and Nutrition Examination Survey 
(NHANES III) in different age and sex specific categories(31). Anthropometrics were 
measured by well-trained research assistants. The presence of hypertension was diagnosed if 
A
D
V
A
N
C
E
 A
R
T
IC
LE
:
T
H
E
 J
O
U
R
N
A
L 
O
F
 C
LI
N
IC
A
L 
E
N
D
O
C
R
IN
O
LO
G
Y
 &
 M
E
T
A
B
O
LI
S
M
JC
EM
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/jc.2018-02792/5445417 by U
niversitaetsbibliothek Bern user on 18 April 2019
AD
VA
NC
E 
AR
TI
CL
E
The Journal of Clinical Endocrinology & Metabolism; Copyright 2019  DOI: 10.1210/jc.2018-02792 
 
 6
either systolic (≥140mmHg) or diastolic (≥90mmHg) blood pressure was increased or the 
participant was on anti-hypertensive medication. Diabetes was defined as fasting glucose 
above 7.0 mmol/L (≥126mg/dL) or drug treatment for elevated blood glucose. Metabolic 
syndrome was diagnosed if three out of five of the following traits were present: 1) high waist 
circumference (≥102 cm for men and ≥88 cm for women), 2) high blood pressure (≥130/85 
mmHg), 3) HDL below 1.0 mmol/L (≤40 mg/dL) in men and below 1.3 mmol/L (≤50 mg/dL) 
in women or the use of lipid-lowering drugs, 4) triglycerides above 1.7 mmol/L (≥150 
mg/dL) in both sexes or the use of lipid-lowering drugs, and finally 5) fasting glucose above 
5.6mmol/L (≥100 mg/dL)(32). Insulin resistance was calculated using the homeostasis 
assessment model of insulin resistance (HOMA-IR): (fasting glucose [mmol/L] x fasting 
insulin [mU/lL]) / 22.5(33).  
Statistical Analyses 
We excluded all participants with missing or unreliab e FFQs, and participants with more 
than 30% missing study variables. Variables were imputed using multiple imputation under 
the fully conditioned specification to reduced bias due to missing data(34). A more detailed 
description on the imputation process can be found in the Supplementary Methods II(21).  
Population characteristics of both the original andimputed data were described using the 
mean (standard deviation, SD), median (25th and 75th percentile, P25-P75), or percentage. We 
carried out analyses of variance (ANOVA) to compare means for different strata (NAFLD vs 
no NAFLD and quartiles of DAL) and Kruskal-Wallis tests to compare medians for different 
strata. Chi-square tests were used to compare categorical variables across strata. We 
calculated Spearman rank correlation coefficients i order to give more insight in the 
correlations of DAL with dietary macronutrients, dietary micronutrients, and DQ. We used 
logistic regression models to assess the association between DAL-proxy categories and 
NAFLD for comparability with other dietary-acid load studies that used categorical analyses 
(17) and to facilitate clinical interpretation. Then we assessed linearity, fitting models with 
splines to allow for non-linearity using natural cubic splines. Thereafter, we tested the need 
for the non-linear terms and optimal degrees of freedom by comparing the spline model 
against linear models with the Akaike Information Criterion. And lastly, we tested the 
relevance of DAL as predictor for NAFLD by comparing the spline model to a model without 
DAL using a likelihood ratio test. 
We adjusted all analyses for potential confounders using 4 models. In model 1, we 
adjusted for potential socio-demographic confounders, i.e. age, sex, education level 
(low/moderate/high), study cohort (RSI/RSII/RSIII), and for energy intake (kilocalories). In 
model 2, we adjusted for lifestyle confounding factors such as alcohol use (in units, one units 
is 10grams), physical activity (MET equivalent hours/week), and smoking (current/past or 
never). In model 3 (the main model) we adjusted for metabolic variables, i.e. HDL-
cholesterol (in mmol/L), triglycerides (in mmol/L), presence of metabolic syndrome, 
estimated GFR (in ml/min/1.73m2), presence of diabetes mellitus and BMI (in kg/m2). And 
finally, in model 4 we tested the potential confounding effect of DQ on the association 
between DAL and NAFLD. The selection of covariates was based on previous literature(35). 
Results were expressed as predicted probability or odds ratio (OR) per quartile, both with the 
accompanying 95% confidence interval (CI). In addition, we tested all models for 
multicollinearity (VIF>5.0). Furthermore, in order to test the robustness of our results we 
performed several sensitivity analyses. First, to account for potential measurement error in 
dietary intake and to remove extraneous variation arising from total energy intake, all DAL-
proxies were adjusted for energy intake using the residual method: that part of the DAL-
proxies that was not explained by total energy intake(36). Second, in order to test the 
robustness of our results, we performed several strtified analyses. We stratified by sex, as 
gender-differences in DAL have been previously suggested(12,17). We stratified by cohort, 
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as participants from various cohorts differ in terms of age (mean age RSIII: 62, RS II: 72, and 
RS I: 79 years old) and because there was a median time-gap of 5.5 years between 
completing the FFQ and performance of ultrasound in cohort three (RS-III, see 
Supplementary Methods I)(21). But as dietary data are known to be stable over time(37), 
RS-III was included in the main analysis. We also stratified by GFR, using 60 ml/min/1.73m2 
as cut-off to distinguish between a normal and impaired renal function (as the kidneys play a 
crucial role in maintaining acid-base balance in the body(38)). We stratified by age (using 65 
as cut-off), as DAL-associations have been previously observed particularly in young 
individuals(39). And finally, we stratified by BMI at a cut-point of 25kg/m2, as participants 
with a normal BMI (lean) could have a different pathophysiological pathway compared to 
overweight participants(12,40). Third, we replaced presence of diabetes with the continuous 
proxy for insulin resistance, HOMA-IR, in model 3, in order to test the hypothesis that the 
mechanistic explanation behind DAL associations are mediated by insulin resistance(41,42). 
And lastly, we alternately excluded the Q1 or the Q4 from the continuous spline analyses in 
order to assess whether it was the alkaline component or the acidic component (respectively), 
or both, that drives the association between DAL-proxies and NAFLD. 
To correct for the inflated type I error that arises due to multiple testing we applied the 
method proposed by Sidák(43), adapted as described in Galwey et al.(44), using the effective 
number of tests (n=1.8) instead of the actual number of tests (n=3). This adaptation is 
necessary to take into account that dietary exposures inter-correlate instead of being 
independent from each other. The resulting corrected significance level for all DAL-proxy 
analyses was P<0.028. All analyses were performed using R version 3.5.1. 
Results 
Participant Characteristics 
In total, 5967 participants were eligible for this study. We excluded unreliable FFQs (n=98; 
1.6%) and missing FFQs (n=1075; 18%). These participants were significantly younger (68.5 
vs 69.6 years; P<0.01), less often of European descent (95% vs 98%; P<0.01), and had a 
higher BMI (27.5 vs 26.9 kg/m2; P<0.01), but there was no difference in steatosis prevalence 
(37.2% vs 35.5%; P=0.27) and sex (55.8% vs 57.5%; P=0.27). Subsequently, we excluded 40 
participants (0.8%) that had >30% of missing data on study variables. Lastly, we excluded 
872 participants (18.3%) with potential secondary causes for steatosis (n=123 steatogenic 
drug use, n=691 alcohol misuse, n=31 viral hepatitis, n=27 combination of the 
aforementioned factors; Supplementary Methods I)(21). Hence, the total study population 
consisted of 3882 participants of which 1337 indiviuals had NAFLD (34.4%). The median 
DAL-proxies in this population were as follows: PRAL -4.7 mEq/day (-15.4; 4.4), NEAP 
35.7 mEq/day (29.6-42.3), and A:P 12.7 (10.2-15.4). Population characteristics on both 
original and imputed data are shown in Supplementary Table 1(21). In short, mean age was 
69.7 years (8.8), median BMI was 26.9 (24.5-29.7), 58.3% was female, and the majority was 
of European descent (97.6%). In Supplementary Table 2 population characteristics are 
shown according to NAFLD stratum(21). Median DAL-proxies were significantly higher in 
participants with NAFLD than in participants without NAFLD, i.e. for PRAL -2.9 vs. -5.5 
mEq/day (P=4.97e-6), for NEAP 37.0 vs. 35.1 mEq/day (P=2.74e-6), and for A:P 13.3 vs. 
12.4 (P=1.70e-10). 
Characteristics of diet-dependent acid load 
Population characteristics per PRAL-quartile are given in Table 1. The median PRAL of Q4 
was 11.1 (7.4; 17.6) mEq/day. In addition, characteristics per NEAP and A:P quartile are 
depicted in Supplementary Table 3 A–B(21). The median NEAP in the Q4 of NEAP was 
47.5 (44.6-53.0) mEq/day, and the median A:P in the Q4 of A:P was 17.8 (16.4-20.1) 
Similar characteristics for Q4 in all DAL-proxies were found, being lower proportion of 
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females, lower physical activity, more current or frmer smokers, higher BMI and higher 
gamma glutamyltransferase. In addition, there were more comorbidities, in particular higher 
prevalence of NAFLD and diabetes (Table 1 and Supplementary Table 3 A - B)(21).  
PRAL, NEAP and A:P correlations with other dietary parameters are depicted in Table 2. 
All DAL-proxies correlated inversely with DQ, meaning that the higher the DAL-proxy the 
lower dietary quality (rs=-0.29 for PRAL, rs=-0.29 for NEAP, and rs=-0.32 for A:P). In 
particular fruit intake had a strong inverse correlation with DAL (rs=-0.51 for PRAL, rs=-0.50 
for NEAP, and rs=-0.37 for A:P). Also, mono and disaccharides and fiber intake were 
inversely correlated (Table 2). As expected, all DAL-proxies correlated positively with 
animal protein (rs=0.26 for PRAL, rs=0.32 for NEAP, and rs=0.51 for A:P). 
Categorized diet-dependent acid load and NAFLD 
The highest quartile (Q4) of PRAL was associated with h gher prevalence of NAFLD (using 
Q1 as reference), in all models (Table 3). However, after correction for multiple testing, the 
association between PRAL and NAFLD was no longer significant in model 3 (ORQ4vsQ1 1.26, 
95%CI 1.01-1.58; P = 0.041). A similar association was seen for NEAP, in which the Q4 of 
NEAP was only significantly associated with NAFLD in model 1 and 2 (model 3: ORQ4vsQ1  
1.24, 95%CI 0.99-1.56; P=0.058). Lastly, the Q4 of A:P had a more pronounced association 
with NAFLD than PRAL and NEAP in the first two models, but this association was 
confounded by metabolic factors –in particular by the metabolic syndrome, BMI, and 
diabetes mellitus– in model 3 (ORQ4vsQ1  1.22, 95%CI 0.97-1.52; P=0.089). 
Continuous diet-dependent acid load and NAFLD 
Logistic regression with natural cubic splines for DAL showed a clear non-linear effect of 
DAL (P for non-linearity for PRAL: 6.5·10-4, NEAP: 3.7·10-4, and A:P: 2.7·10-5) . The 
predicted probability of NAFLD in model 3 (metabolic) was lowest within the alkaline PRAL 
range -45 to -4 mEq/day, with a minimum predicted probability of NAFLD that was 29%. 
Whereas the predicted probability of NAFLD increased to 36% for acidic PRAL-values 9 to 
11 mEq/day (equals Q4; Figure 1A). A similar shape was seen for NEAP and A:P (Figure 
1B – C). For NEAP Q1 and Q2 NAFLD probability was low (<33%), but increased for 
towards 37% (Figure 1B). For Q1 and Q2 of A:P probability of NAFLD was low (again 
<33%), and the highest predicted probability of NAFLD (36%) was seen at an A:P of 17 in 
(again equals Q4; Figure 1C). The shape of the splines for models 1 and 2 were v ry similar 
to that of model 3, but generally with higher predicted probabilities of NAFLD and more 
pronounced differences between high and low DAL (Supplementary Figure 1 A – B)(21). 
All models performed better with DAL in the model than without DAL, this even remained 
significant for NEAP and A:P after multiple comparison correction (log-likelihood ratio test: 
P = 0.038 for PRAL; P = 0.015 for NEAP; P = 0.012 for A:P). 
Diet-dependent acid load and potential confounding by dietary quality 
We assessed whether DAL was confounded by DQ in a sep rate model 4. Categorical 
analyses of DAL-proxies with NAFLD adjusted for DQ are depicted in Table 3; model 4. 
Although the results were not statistically significant, the associations hardly attenuated after 
adjustment of DQ. Hence, DQ could not fully explain the association between DAL and 
NAFLD. The same effect of DQ was seen on the splines (Supplementary Figure 1C: PRAL 
P=0.043, NEAP P=0.017; and A:P P=0.014, comparing the models with and without DAL-
proxies)(21). 
Sensitivity analyses 
To test the robustness of our findings we carried out multiple sensitivity analyses. First, we 
used the residual method to account for extraneous variation in DAL arising from total 
energy intake. The associations with PRAL attenuated slightly, but the results for NEAP and 
A:P were similar to the main analysis (Supplementary Table 4)(21). Second, we stratified 
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by several predefined covariates (Supplementary Tables 5-9)(21). All stratified results 
largely resembled the original analyses (Figure 2). Interestingly, PRAL was nominally 
significant associated with higher NAFLD prevalence in participants with an impaired kidney 
function after full adjustment in the metabolic model (ORQ4vsQ1 1.81 95%CI 1.01-3.24, P = 
0.047, Supplementary Table 7)(21). Third, we have additionally adjusted model 3 for 
insulin resistance (instead of diabetes presence, using HOMA-IR) and found that the 
association dissipated, indicating the mediating role of insulin resistance in this association 
(ORQ4vsQ1 for PRAL: 1.19, 95%CI 0.95-1.50; for NEAP 1.15 95%CI 0.88-1.38; for A:P 1.12 
95%CI 0.89-1.41). And fourth, in order to assess whether it is the acidic component or the 
alkaline component that drives the association betwe n DAL-proxies and NAFLD, we 
alternately excluded the alkaline component (Q1) and  the acidic component (Q4) from the 
analyses. All models with DAL-proxies performed better han models without DAL-proxies 
only when the alkaline component was excluded, but not when the acidic component was 
excluded (log-likelihood ratio test excluding Q1: P=0.032 for PRAL; P=0.015 for NEAP; 
P=0.010 for A:P; log-likelihood ratio test excluding Q4: P=0.310 for PRAL; P=0.115 for 
NEAP; P=0.253 for A:P) This may indicate that it is the acidic component drives the 
association between DAL-proxies and NAFLD. 
Discussion 
In this largest population-based cohort study to date, we found that diet-dependent acid load, 
as assessed by net-endogenous acid production and animal protein-to-potassium ratio, was 
independently associated with NAFLD. This association was not linear; but the highest 
probability of NAFLD (36-37%) was found for an acidi  diet and the minimum predicted 
probability of NAFLD (29%) for an alkaline diet. Indeed, the association was driven mainly 
by the acidic component of the diet. Models with NEAP and A:P performed significantly 
better in predicting NAFLD than without these indices of DAL, importantly, even after 
correction for numerous confounders such as BMI and overall dietary quality. Moreover, the 
association between DAL-proxies and NAFLD was tested for in different subgroups of the 
population which showed overall consistent results.  
Despite all ongoing pharmacological studies, lifestyle intervention remains the only 
available treatment for NAFLD today(45). Recently, several studies found detrimental 
associations between high animal protein intake (10,46) and NAFLD. Amongst them, a 
recent study from Zelber-Sagi and colleagues found that high red and processed meat 
consumption was associated with NAFLD and insulin resistance(47). This is in line with 
another recent study from Etemadi et al. that showed that a diet rich in red meat was 
associated with higher incidence of liver-related mortality(11). Food items from the Western 
dietary pattern, such as red meat, generally contribute to a higher diet-dependent acid 
load(38). Indeed, animal protein had the highest poitive correlation with all DAL-proxies in 
our study as well. Interestingly, the highest inverse correlation with DAL-proxies was found 
for mono-and disaccharides. This is in line with our previous study in which we found an 
inverse association of mono-and disaccharides with NAFLD, though this was not 
independent from metabolic confounders. We also know that fruit was by far the most 
contributing group to this macronutrient. And fruits have indeed a alkalinizing potential(38).  
In this study we show that in particular an acidic iet was associated with higher NAFLD 
prevalence, and we therefore hypothesize that diet-dependent acid load may (partially) 
explain the link between an animal protein-rich diet and NAFLD. Interestingly, our findings 
are in line with two previous studies on DAL and NAFLD(16,17). A study in German 
adolescents found that PRAL was associated with ALT, fatty liver index and hepatic steatosis 
index in girls but not in boys(17). However, the study population was small (n=145), the 
study only included adolescents and young adults (mean age 20 years old), and steatosis 
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algorithms were assessed only continuously (but prevalence was most probably low as 
median FLI was ± 10). Another elegant study analysed PRAL and NEAP in association with 
NAFLD (assessed by MRI-PDFF), in 793 Chinese adults(16). The authors found an 
association between NEAP and NAFLD in multivariable analysis. However, linearity of 
PRAL and NEAP was not assessed in these two studies(16,17), which makes direct 
comparison (along with major sociodemographic differences) to our Western adult 
population difficult. Of note, mean diet-dependent acid load in the latter study was rather 
high (PRAL 24 mEq/day and NEAP 77 mEq/day)(16) in comparison to our study and that of 
others which was relatively more alkaline (i.e. the Rotterdam Study: PRAL -4.7mEq/day and 
NEAP 36 mEq/day; Nurses’ Health Study: PRAL -3.1 mEq/day and NEAP: 44 mEq/day; and 
Health Professionals’ Follow-up Study: PRAL 5.7 mEq/day and NEAP 48 mEq/day)(12). 
Diet-dependent acid load has also been implicated in other health outcomes that are 
related to  NAFLD, such as type 2 diabetes and hypertension(38). An interesting Swedish 
study examined whether PRAL was associated with overall mortality in over 80.000 
individuals followed for 13 years(48). Similar to our study, the authors found a non-linear 
association between PRAL and all-cause mortality bu rather a U-shaped spline. Thus, both 
dietary acid and alkali excess were associated with increased mortality risk. We did not 
observe a clear U-shape in our splines, but the predicted probability of NAFLD was indeed 
also higher in the distinct alkaline diets. To date, th re is no study that showed that a diet high 
in alkaline load is detrimental for health, however, one could speculate that a one-sided, 
unbalanced diet might be unhealthy anyway – possibly also via other mechanisms than diet-
dependent acid load alone. Rightfully so, the authors of this Swedish study argued whether 
the low impact (HR 1.06) of PRAL on mortality risk is important in terms of public health. 
Indeed, there are studies that found no association between diet-dependent acid load and 
health(49,50). Differences in sociodemographic factors such as age, gender, ethnicity, and 
dietary habits could have contributed to these contrasting results. We have therefore 
performed several predefined subgroup analyses. Most subgroup analyses were not 
statistically significant, but should be interpreted in light of lower statistical power, and 
generally confirmed the main results. Yet, the highest quartile of PRAL was nominally 
significant in participants with an impaired renal function (estimated GFR < 60 
ml/min/1.73m2) and, albeit not significant, the same trend was seen for both NEAP and A:P. 
The results were not significant after multiple testing correction, but again, they should be 
interpreted in light of lower power (n=597). This fnding is not surprising as the kidney plays 
a crucial role in maintaining acid-base balance(51). Likewise, a long-term high diet-
dependent acid load could also contribute to the dev lopment of chronic kidney disease by 
increasing endothelin-1, angiotensin-II, and aldosterone production to meet the demand for 
hydrogen excretion(52). 
Mechanistically, it is thought that consumed proteins, in particular sulphur-containing 
amino-acids (e.g. methionine and cysteine) found in animal proteins, form sulphate after 
oxidation(38). This is a non-volatile acid that can be neutralized by bicarbonate but forms a 
hydrogen-bond as end product. In contrast, plant protein often contains glutamate which can 
be metabolized without this formation. Fruit on theother hand, is potassium-rich and often 
accompanied by citrate and malate, which consume hydrogen-bonds to become neutral and 
hence are alkalinizing(53). This low-grade or subclini al metabolic acidosis has been 
associated with various metabolic alterations(54). Amongst others, a change in glucose 
homeostasis has been found, being a lower insulin response to high glucose in the presence of 
a low pH(41). Also, long-term subclinical metabolic a idosis may increase adrenal cortisol 
production (modulated by the hypothalamic-pituitary- drenal axis) and subsequently may 
lead to visceral obesity and insulin resistance(42,55). In our study, adjustment for insulin 
resistance, as assessed by HOMA-IR, weakened the associ tion between DAL and NAFLD, 
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confirming our hypothesis that the association betwe n DAL and NAFLD is mediated via 
insulin resistance(41,42). Based on experimental studies, it has been proposed that low-grade 
metabolic acidosis influenced the growth hormone/ isulin growth factor 1 system, leading to 
hepatocellular growth hormone resistance and subseqent hepatic lipid accumulation(56,57). 
Opponents of the diet-dependent acid load hypothesis argue that DAL-proxies are merely a 
different way of scoring adherence to a healthy diet. Although we cannot exclude this 
possibility, separate correction for adherence to dietary quality did not fully explain the 
association between DAL and NAFLD. Indeed, food items can effectuate health changes 
without affecting acid-base balance. For example, fruits and vegetables also contain dietary 
fiber that is beneficial for glycemic control(58). Also, it has been suggested that the 
metabolization of sulphur-containing amino-acids (i.e. methionine and cysteine found in 
animal protein) in the liver can directly cause liver injury(59). Lastly, an experimental rat 
study found that a high protein diet upregulated mRNA expression of genes encoding 
proteins involved in amino acid uptake and enhanced lipid synthesis(60). In this study, 
hepatic mRNA and protein levels of heat shock protein 90, a marker of liver injury, were 
markedly increased in these rats fed a high-protein diet. Of note, high protein intake did not 
result in elevated hepatic lipid concentrations in these rats. 
Our study has several strengths, including a large sample size, availability of a great 
number of well-defined covariates, the (predefined) subgroup analyses to confirm the 
robustness of our findings, the evaluation of linearity and subsequent use of natural cubic 
splines, and the correction for multiple testing. Nonetheless, there are several considerations 
that need to be addressed. First, this study comprises a large predominantly elderly and 
Caucasian population, with a relatively alkaline dit. Despite the reassuring similar results in 
several subgroups of participants, caution on generalizability should be exercised. Second, 
due to the cross-sectional design of this study it is not possible to draw any conclusions on 
causality. Third, although we have corrected for a large number of different traits, we cannot 
exclude the possibility of residual confounding. Fourth, as with any self-administered 
questionnaire, the FFQ is susceptible for recall and reporter bias. Nonetheless, we have tried 
to limit this bias by excluding potential unreliable FFQs and by performing a sensitivity 
analyses with DAL-proxies corrected by the residual method to account for extraneous 
variation in energy intake. Fifth, one of the three included cohorts (RS III) completed the 
FFQ 5.5 years prior to liver imaging. We assumed that dietary data was stable over time(23), 
which was indeed recently shown in another paper from The Rotterdam Study(61). 
Nonetheless, we used study cohort as covariables in all regression models, moreover, we 
performed sensitivity analysis per study cohort. All the separate cohorts showed results that 
were comparable to the main analysis. Sixth, we used ltrasonography to assess steatosis, 
which has a good sensitivity to detect moderate steatosis but is poor in detecting mild 
steatosis and in grading steatosis. Moreover, the golden standard to assess NAFLD –and its 
advanced subtype non-alcoholic steatohepatitis– is a liver biopsy. However, it is unethical to 
perform this invasive procedure on a large scale in presumed healthy individuals. Finally, we 
had no dispose of acid-base biomarkers to estimate actual metabolic acidosis. However, 
NEAP and PRAL have been previously validated in healt y individuals and accounted for 
71% of the variation in renal net acid excretion (15,25). And, although A:P has not been 
validated as of yet, results of A:P were very comparable to NEAP and PRAL. 
In conclusion, this study shows that an acid-base (un)balanced diet is associated with 
NAFLD and that differences in sociodemographics, lifestyle, metabolic factors, and dietary 
quality did not fully explain the observed associations. Though the results should be 
interpreted in context of a relatively alkaline diet, our findings might explain the previously 
observed association of an animal protein-rich diet w th NAFLD. Future research initiatives 
should use acid-base biomarkers, such as urinary ammonium(62), to study low-grade 
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metabolic acidosis more objectively. Nevertheless, dietary recommendations that are in 
agreement with an acid-base balanced diet, i.e. a diet rich in fruit and vegetables and poor in 
animal protein, are generally considered beneficial for health. Therefore, adherence to such a 
diet low in animal protein while awaiting the result  of future studies seem justifiable.  
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Figure 1: Natural cubic splines for the association of A: PRAL, B: NEAP, and C: A:P 
with the predicted probability of NAFLD in (metabol ic) model 3. A: Model with PRAL 
vs. model without PRAL (P=0.038). B: Model with NEAP vs. model without NEAP 
(P=0.015). C: Model with A:P vs. model without A:P (P=0.012). Y-axis represents predicted 
probability of NAFLD in (metabolic) model 3: NAFLD ~ DAL-proxy + age + gender + 
education level + energy intake + study cohort +  smoking + units of alcohol + physical 
activity + HDL-cholesterol + triglycerides + metabolic syndrome + GFR + diabetes mellitus 
+ BMI.  X-axis represent values of PRAL, NEAP or A:P. The grey-colored bar represents the 
95% confidence interval. The upper and lower 2.5th centile were excluded from the graphs. 
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary 
acid load; DQ: dietary quality; GFR: glomerular filtration rate; NAFLD: non-alcoholic fatty 
liver disease; NEAP: net endogenous acid production; PRAL; potential renal acid load. 
Figure 2: Associations of DAL-proxies with NAFLD stratified by various covariates in 
the metabolic model. Values are odds ratios of the fourth quartile with 95% confidence 
intervals taking the first quartile as reference. All strata are analysed within modified 
(metabolic) model 3: NAFLD ~ DAL-proxy + (age) + (gender) + education level + energy 
intake + (study cohort) +  smoking + units of alcohol + physical activity + HDL-cholesterol + 
triglycerides + metabolic syndrome + (GFR) + diabetes mellitus + (BMI). This figure 
represents data that can also be found in more detail in Supplementary Table 4 – 9. 
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary 
acid load; GFR: glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: 
net endogenous acid production; PRAL; potential renal acid load. 
Table 1: Characteristics per quartile PRAL 
PRAL  
 Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-value 
DAL       
PRAL -24.4 (-33.7 ; -
19.1)  
-9.7 (-12.5 ; -7.2) -0.33 (-2.3 ; 1.9) 11.1 (7.4 ; 17.6) n/a 
NEAP 25.6 (21.9 – 28.4) 32.7 (30.9 – 34.3) 38.7 (37.0 – 40.7) 47.4 (44.1 – 52.9) <0.001 
A:P 9.2 (7.6 – 10.5) 11.7 (10.4 – 13.2) 13.9 (12.4 – 15.4) 17.2 (15.0 – 19.9) <0.001 
Demographics       
Age 70.2 (8.8) 69.8 (8.6) 69.8 (8.8) 69.1 (9.2) 0.057 
Female (%) 67.6 62.5 54.9 48.2 <0.001 
Caucasian (%) 97.6 97.9 97.8 97.2 0.804 
Education Level (%)      
Low 48.4 49.7 47.9 47.7 0.167 
Intermediate 27.7 29.4 31.6 32.5  
High 23.9 20.9 20.5 19.8  
Smoking status (%)      
Never 39.5 37.7 34.5 32.6 0.009 
Current / Former 60.5 62.3  
 65.5 
67.4  
Alcohol (units/d) 0.45 (0.04 – 1.16) 0.49 (0.08 – 1.22) 0.45 (0.07 – 1.22) 0.43 (0.03 – 1.17) 0.203 
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Physical Activity 
(METh/wk) 
46.4 (18.5 – 84.5) 43.0 (17.0 – 78.8) 37.0 (14.3 – 74.5) 34.6 (13.5 – 73.2) <0.001 
Energy intake (kcal/d) 2175 (1823 – 
2667) 
1929 (1557 – 2363) 1891  (1488 – 2360) 2105  (1700 – 2668) <0.001 
Physical examination      
BMI (kg/m2) 26.5 (24.3 – 29.4) 26.8 (24.5 – 29.4) 27.0 (24.6 – 29.9) 27.2 (24.7 – 30.0) 0.010 
Biochemistry      
AST (U/L) 24 (21 – 28) 24 (21 – 28) 24 (21 – 28) 25 ( 1 – 29) 0.125 
ALT (U/L) 18 (14 – 24) 18 (14 – 23) 18 (14 – 24) 20 (15 – 25) <0.001 
GGT (U/L) 21 (16 – 30) 22 (16 – 32) 23 (17 – 34)  25 (18 – 37) <0.001 
Platelets (*109/L) 269 (232 – 309) 263 (224 – 305) 259 (220 – 303) 257 (218 – 303) 0.002 
HOMA-IR  2.4 (1.7 – 3.7) 2.5 (1.7 – 3.9) 2.6 (1.7 – 4.2) 2.9 (1.8 – 4.6) <0.001 
Total Cholesterol (mmol/L) 5.6 (1.1) 5.5 (1.1) 5.4 (1.1) 5.3 (1.1) <0.001 
HDL-C (mmol/L) 1.5 (0.4) 1.5 (0.4) 1.5 (0.4) 1.4 (0.4)  <0.001 
Triglycerides (mmol/L) 1.3 (1.0 – 1.7) 1.3 (1.0 – 1.7) 1.3 (1.0 – 1.7) 1.3 (1.0 – 1.8) 0.482 
GFR  76 (66 – 86) 76 (66 – 86) 75 (66 – 85) 76 (65 – 86) 0.796 
Comorbidities      
Metabolic Syndrome 48.4 49.7 54.2 57.1 0.003 
- Waist circumference 40.2 43.2 43.8 45.6 0.112 
- Triglycerides  41.6 45.4 48.4 48.5 0.007 
- HDL-Cholesterol  40.1 44.7 46.5 47.2 0.007 
- Blood pressure  84.6 85.0 83.7 83.7 0.794 
- Fasting   Glucose 41.8 45.1 46.6 53.5 <0.001 
Diabetes Mellitus (%) 11.1 11.6 12.5 17.3 <0.001 
Hypertension (%) 73.8 75.7 72.1 74.3 0.363 
NAFLD 30.9 31.8 35.2 39.9 <0.001 
Data is expressed as mean (SD), median (P25-P75) or percentage. *P-value is based on ANOVA, Kruskall-
Wallis test or Chi-square test.  
Abbreviations ALT: alanine aminotransferase; A:P: animal protein to potassium ratio; AST: aspartate 
aminotransferase; BMI: body mass index; DAL: dietary cid load; GFR: glomerular filtration rate; GGT: 
gamma-glutamyltransferase; HDL-C: high-density lipoprotein cholesterol; HOMA-IR: homeostasis model 
assessment of insulin resistance; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid 
production; PRAL; potential renal acid load. 
Table 2: Correlations between DAL-proxies and diet 
 PRAL  NEAP A:P 
 rs rs rs 
Total protein (g)    0.17    0.23    0.21 
Animal protein    0.26    0.32    0.51 
Vegetable protein -  0.08 -  0.03 -  0.31 
Total carbohydrates (g) -  0.27 -  0.23 -  0.32 
Mono-and disaccharides -  0.45 -  0.42 -  0.35 
Polysaccharides    0.02    0.06 -  0.20 
Fiber  -  0.40 -  0.36 -  0.48 
Total fat (g)    0.20    0.25    0.12 
Saturated fat     0.24    0.27    0.21 
Mono-unsaturated fatty acids    0.20    0.25    0.12 
Poly-unsaturated fatty acids    0.11    0.16 -  0.04 
Trans fatty acids     0.23    0.24    0.18 
Minerals (mg)    
Vitamin E  -  0.03    0.03 -  0.09 
Magnesium  -  0.23 -  0.18 -  0.26 
Potassium  -  0.44 -  0.39 -  0.30 
Phosphorus     0.05    0.08    0.08 
Calcium   - 0.05  - 0.03    0.06 
DQ score (points) -  0.29 -  0.29 -  0.32 
↑Vegetables -  0.27 -  0.23 -  0.24 
↑Fruit -  0.51 -  0.50 -  0.37 
↑Whole grain products    0.09    0.10 -  0.12 
↑Legumes -  0.03 -  0.01 -  0.08 
↑Nuts    0.03    0.04 -  0.09 
↑Dairy -  0.02 -  0.04    0.09 
↑Fish    0.04    0.08    0.14 
↑Tea -  0.05 -  0.05 -  0.05 
↑Whole/Refined grains -  0.04 -  0.06 -  0.13 
↑Unsaturated fats/oils -  0.06 -  0.05 -  0.06 
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↓Red and processed meat -  0.17 -  0.22 -  0.32 
↓Sugar containing drinks    0.07    0.06    0.06 
↓Alcohol -  0.02 -  0.01 -  0.02 
↓Salt -  0.22 -  0.25 -  0.13 
By Spearman’s rank correlation. DQ score can theoretically vary from 0-14 points. DQ subtypes are 
dichotomous.  
Legend Spearman correlation: 
negative positive 
moderate weak very weak very weak weak moderate 
-0.59 to -0.40 -0.39 to -0.20 -0.19 to -0 0 to 0.19 0.20 to 0.39 0.40 to 0.59 
Abbreviations A:P: animal protein to potassium ratio; DAL: dietary cid load; NEAP: net endogenous acid 
production; PRAL; potential renal acid load. 
Table 3: Logistic regression analyses of DAL-proxies with NAFLD as dependent variable 
Total population (n=3882) 
 Q2 Q3 Q4 
PRAL n per quartile (n=970) (n=971) (n=970) 
NEAP n per quartile (n=970) (n=971) (n=970) 
A:P n per quartile (n=970) (n=971) (n=970) 
Model 1 (sociodemographic) 
PRAL  0.99 (0.81 – 1.20) 1.14 (0.94 – 1.38) 1.42 (1.17 – 1.72)† 
NEAP 1.02 (0.84 – 1.24) 1.24 (1.02 – 1.50) 1.40 (1.15 – 1.69)† 
A:P 1.14 (0.94 – 1.39) 1.36 (1.12 – 1.65)† 1.63 (1.35 – 1.97)† 
Model 2 (lifestyle) 
PRAL  0.98 (0.81 – 1.19) 1.12 (0.92 – 1.36) 1.38 (1.14 – 1.67)† 
NEAP 1.03 (0.85 – 1.25) 1.22 (1.01 – 1.48) 1.36 (1.12 – 1.65)† 
A:P 1.14 (0.94 – 1.39) 1.33 (1.09 – 1.61)† 1.58 (1.31 – 1.92)† 
Model 3 (metabolic) 
PRAL  0.97 (0.77 – 1.21) 1.09 (0.87 – 1.36) 1.26 (1.01 – 1.58) 
NEAP 0.97 (0.78 – 1.22) 1.18 (0.94 – 1.47) 1.24 (0.99 – 1.56) 
A:P 0.96 (0.77 – 1.21) 1.09 (0.87 – 1.36) 1.22 (0.97 – 1.52) 
Model 4 (metabolic + DQ) 
PRAL  0.97 (0.77 – 1.21) 1.09 (0.87 – 1.37) 1.27 (1.01 – 1.60) 
NEAP 0.98 (0.78 – 1.22) 1.18 (0.94 – 1.47) 1.25 (0.99 – 1.57) 
A:P 0.96 (0.77 – 1.21) 1.09 (0.87 – 1.37) 1.22 (0.97 – 1.54) 
Values are odds ratios with 95% confidence intervals t king quartile 1 as reference. Bold values indicate 
P<0.05. † Indicates significant values using P < 0.028 as determined by Sidák. 
Model 1 (socio-demographic) is adjusted for age, gender, education level, energy intake and study cohort. 
Model 2 (lifestyle) is in addition previous model adjusted for past or current smoking, units of alcohol, and 
physical activity . 
Model 3 (metabolic) is in addition to the previous model adjusted for HDL-cholesterol, triglycerides, metabolic 
syndrome, GFR, diabetes mellitus and BMI. 
Model 4 (metabolic + DQ) is in addition to the previous model adjusted for DQ. 
Abbreviations A:P: animal protein-potassium ratio; DQ: Dietary Quality; NEAP: net endogenous acid 
production; PRAL: potential renal acid load; Q: Quartile. 
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: 
dietary quality; GFR: glomerular filtration rate; HDL: high density lipoprotein; NAFLD: non-alcoholic fatty 
liver disease; NEAP: net endogenous acid production; PRAL; potential renal acid load. 
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